IRhythm Technologies Inc. $(IRTC)$ has announced the results from two significant real-world studies at the American Diabetes Association's 85th Scientific Sessions (ADA 2025) in San Francisco. The studies focused on cardiac arrhythmias in patients with type 2 diabetes, some of whom also have chronic kidney disease. The findings indicate that cardiac arrhythmias are common and often occur early in these patients, frequently preceding major cardiovascular events. The analyses utilized longitudinal claims data from over 30 million U.S. adults, highlighting the potential for enhanced early detection strategies in at-risk populations. These results underscore the importance of monitoring patients based on unique risk factors rather than symptoms alone, as many arrhythmias are asymptomatic.